Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Palliative surgery versus medical management for bowel obstruction in ovarian cancer.

Kucukmetin A, Naik R, Galaal K, Bryant A, Dickinson HO.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007792. doi: 10.1002/14651858.CD007792.pub2. Review.

2.

Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.

Ang C, Chan KK, Bryant A, Naik R, Dickinson HO.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD007697. doi: 10.1002/14651858.CD007697.pub2. Review.

3.

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Review.

PMID:
21833960
4.

Surgical cytoreduction for recurrent epithelial ovarian cancer.

Al Rawahi T, Lopes AD, Bristow RE, Bryant A, Elattar A, Chattopadhyay S, Galaal K.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD008765. doi: 10.1002/14651858.CD008765.pub3. Review.

PMID:
23450588
5.

Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent).

Gurumurthy M, Bryant A, Shanbhag S.

Cochrane Database Syst Rev. 2014 Apr 21;(4):CD006912. doi: 10.1002/14651858.CD006912.pub2. Review.

PMID:
24753008
6.

Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.

Wuntakal R, Seshadri S, Montes A, Lane G.

Cochrane Database Syst Rev. 2016 Jun 29;(6):CD011322. doi: 10.1002/14651858.CD011322.pub2. Review.

PMID:
27356090
7.

Exenterative surgery for recurrent gynaecological malignancies.

Ang C, Bryant A, Barton DP, Pomel C, Naik R.

Cochrane Database Syst Rev. 2014 Feb 4;(2):CD010449. doi: 10.1002/14651858.CD010449.pub2. Review.

PMID:
24497188
8.

Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.

Eleje GU, Eke AC, Igberase GO, Igwegbe AO, Eleje LI.

Cochrane Database Syst Rev. 2015 May 1;(5):CD011000. doi: 10.1002/14651858.CD011000.pub2. Review.

PMID:
25932968
9.

Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.

Lawrie TA, Nordin A, Chakrabarti M, Bryant A, Kaushik S, Pepas L.

Cochrane Database Syst Rev. 2016 Jan 5;(1):CD011837. doi: 10.1002/14651858.CD011837.pub2. Review.

PMID:
26728940
10.

Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.

Abdul Razak AR, Li L, Bryant A, Diaz-Padilla I.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007584. doi: 10.1002/14651858.CD007584.pub2. Review.

11.

Interventions for the treatment of borderline ovarian tumours.

Faluyi O, Mackean M, Gourley C, Bryant A, Dickinson HO.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007696. doi: 10.1002/14651858.CD007696.pub2. Review.

12.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Lawrie TA, Winter-Roach BA, Heus P, Kitchener HC.

Cochrane Database Syst Rev. 2015 Dec 17;(12):CD004706. doi: 10.1002/14651858.CD004706.pub5. Review.

PMID:
26676202
13.

Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.

Cousins SE, Tempest E, Feuer DJ.

Cochrane Database Syst Rev. 2016 Jan 4;(1):CD002764. doi: 10.1002/14651858.CD002764.pub2. Review.

14.

Medical interventions for high-grade vulval intraepithelial neoplasia.

Pepas L, Kaushik S, Nordin A, Bryant A, Lawrie TA.

Cochrane Database Syst Rev. 2015 Aug 18;(8):CD007924. doi: 10.1002/14651858.CD007924.pub3. Review.

PMID:
26284429
15.

Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.

Kokka F, Bryant A, Brockbank E, Powell M, Oram D.

Cochrane Database Syst Rev. 2015 Apr 7;(4):CD010260. doi: 10.1002/14651858.CD010260.pub2. Review.

PMID:
25847525
16.

Lymphadenectomy for the management of endometrial cancer.

Frost JA, Webster KE, Bryant A, Morrison J.

Cochrane Database Syst Rev. 2015 Sep 21;(9):CD007585. doi: 10.1002/14651858.CD007585.pub3. Review.

PMID:
26387863
17.

Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.

Galaal K, Naik R, Bristow RE, Patel A, Bryant A, Dickinson HO.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007822. doi: 10.1002/14651858.CD007822.pub2. Review.

18.

Epidermal growth factor receptor blockers for the treatment of ovarian cancer.

Haldar K, Gaitskell K, Bryant A, Nicum S, Kehoe S, Morrison J.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007927. doi: 10.1002/14651858.CD007927.pub3. Review.

PMID:
21975775
19.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Winter-Roach BA, Kitchener HC, Dickinson HO.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004706. doi: 10.1002/14651858.CD004706.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD004706.

PMID:
19160239
20.

Resection versus other treatments for locally advanced pancreatic cancer.

Gurusamy KS, Kumar S, Davidson BR, Fusai G.

Cochrane Database Syst Rev. 2014 Feb 27;(2):CD010244. doi: 10.1002/14651858.CD010244.pub2. Review.

PMID:
24578248

Supplemental Content

Support Center